Lymphangiogenesis

pathway activity — cross-omics
GO:0001946Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Lymphangiogenesis pathway is significantly associated with the RNA expression of multiple genes, with the LSCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are CSMD2, RUBCNL, and PROX1, each associated with the pathway in up to 6 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Lymphangiogenesis activity versus CSMD2 in LSCC (Pearson r = 0.31).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LSCCCSMD2 →+0.742+0.278<.001<.00135
GBMRUBCNL →+0.812+0.706.001<.00135
GBMPROX1 →+1.276+0.552<.001<.00135
LSCCACTA2 →+0.779+0.191<.001<.00135
BRCAPRRX1 →+1.029+0.314.001.00435
BRCATNFAIP6 →+0.904+0.332.001<.00126
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0001946 vs CSMD2 — LSCC

Per-sample scatter of Lymphangiogenesis activity vs CSMD2 in LSCC.

Explore this scatter interactively →

Exploration